Article
Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation.
Clinical endocrinology - 1 Feb 2005
Araujo Rogério S, Billerbeck Ana Elisa C, Madureira Guiomar, Mendonca Berenice B, Bachega Tânia A S S
Abstract excerpt
The classical and nonclassical phenotypes of 21-hydroxylase deficiency represent a continuous spectrum of the impairment of 21-hydroxylase activity due to mutations between the CYP21A2 gene. These mutations occur mainly by microconversion in the homologous nonfunctional CYP21A1P gene. The P30L mutation is associated with the nonclassical form, and it reduces the activity to 30-40% of the normal enzyme. We have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
